Enhancer of zeste homolog 2 (EZH2) activates Ras and p65/RelA (a measure of NF-κB activity) [17], and high EZH2 expression has been correlated with poor prognosis in several tumors, including gastric cancer [18]. This evidence concerns the gene RELA and gastric cancer.